Skip to main content
Premium Trial:

Request an Annual Quote

Epoch Secures Patent Protection for MGB Technology

NEW YORK, Feb. 4 (GenomeWeb News) - Epoch Biosciences today said it has been granted a US patent related to the Minor Grove Binder (MGB) technology that underlies its MGB Eclipse Probe genetic analysis system. 

The patent - number 6,683,173, entitled "Tm (DNA Hybridization) Leveling Methods" - covers the use of modified oligonucleotides in designing probes and primers that work in the narrow temperature range used in genetic analysis systems. According to Epoch, "this development greatly improves the performance of hybridization-based systems for genetic analysis," including SNP detection and gene expression analysis.

The MGB technology is used in Epoch's MGB Eclipse Probe Systems, as well as Applied Biosystems' MGB-TaqMan products and BioControl System's food-testing products.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.